Article
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor.
Anticancer research - 1 Apr 2013
Nair Jayasree S, Sheikh Tahir, Ho Alan L, Schwartz Gary K
Abstract excerpt
De-regulated expression of components of the Notch signaling pathway is observed in malignant melanoma. This pathway is activated by catalytic cleavage of the Notch receptor by γ-secretase. Phase-I trials with RO4929097, a potent gamma secretase inhibitor (GSI), and other agents of this class have demonstrated clinical activity in patients with melanoma. An understanding of the mechanisms for de novo sensitivity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
